STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

FENNEC PHARMACEUTICALS INC.

Filed

October 9, 2025

Period of Report

October 7, 2025

Accession Number

0001012975-25-000621